Menu

Paula Deen Hawking Diabetes Meds – how convenient! #lowcarb #paleo #diabetes

Paula Deen is now working for and shilling for Novo Nordisk (Novo’s press release). Yup, she has openly admitted that she will be promoting the pharmaceutical companies product, Deen says. “Talking about money is garish. It’s tacky. But, of course, I’m been compensated for my time. That’s the way our world works.”

“GARISH!”

In my life I have found that only people with lots of money or no money can say that, I feel Paula is on the richer side of things. We don’t have to worry about  her son Bobby’s finances since three weeks before her revelation, “Deen’s son Bobby launched a new Cooking Channel show called “Not My Momma’s Meals,” featuring lighter versions of his mother’s dishes.”

Read more: http://www.vancouversun.com/health/Opinion+Paula+Deen+diabetes+revelation+really+hard+swallow/6049454/story.html#ixzz1kUZdiTMg Senator Grassley should investigate the money that pharmaceutical companies pay celebrities such as Paula Deen and push to have these payments made public just like pharma payments to physicians must be made public.

Deen claims to use Novo Nordisk’s Victoza, a once-daily, non-insulin injection that may improve blood sugar levels in adults with type 2 diabetes when used along with diet and exercise.

It also appears that Deen will NOT change her lifestyle — ie, eating habits — much to encourage PREVENTION of type 2 diabetes.

“Type 2 diabetes is like ‘Russian roulette’ when it comes to whom it’s going to strike, Deen says. ‘It’s about heredity. It’s about age, lifestyle, race. I’m the only one in my family who has it. My grandmother cooked and ate like I ate, and she didn’t have it.’

“Deen says she’s not going to change the focus of her cooking shows because of diabetes. ‘I suspect I’ll stick to my roots but will say a little louder, Eat this in moderation.'”

Novo Nordisk appears to be abandoning life style changes it has supported in the past or maybe it’s just exhibiting a form of PR-Marketing schizophrenia.

Just this past November on World Diabetes Day, for example, the company issued a press release in which it announced that it was a partner in the World Diabetes Day campaign and that it “has planned or co-sponsored a variety of activities throughout the world…[all of which] are focused on increasing awareness and improving knowledge of diabetes and its prevention” (see “Dramatic increase in diabetes prevalence calls for action“).

The two activities just do not fit together! The first (sponsoring World Diabetes Day) is a matter of public relations and the second (Paula Deen) is marketing’s turf — never the twain shall meet.

Novo and Paula have launched a new Website (registered for the first time on Dec-7-2011, followed by Deen’s press release) whose very name hints at the new emphasis: “Diabetes in a new light!™” (www.diabetesinanewlight.com)

Apparently, Novo Nordisk is more interested in helping people live with type 2 diabetes by treating it than it is in helping 26 million Americans prevent it.